Pulmonary Hypertension Research and Treatments
Moving in European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, Annals of the Rheumatic Diseases, Circulation Research, Arteriosclerosis, Thrombosis, and Vascular Biology, Arthritis & Rheumatology, British Journal of Pharmacology and bioRxiv.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 87
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Pulmonary Hypertension Research and Treatments
Newest first · last 60 days
AI summary · may contain errors
In surgically induced pulmonary arterial hypertension in 17–19-day-old male Cobb broilers, HFS and Momordica charantia supplementation both reduced ventricular index, with a larger reduction in HFS.
- Open access
AI summary · may contain errors
Myeloid-specific ZEB1 deletion in hypoxia-induced pulmonary hypertension mice attenuates macrophage inflammation, pulmonary vascular remodeling, and right ventricular dysfunction.
AI summary · may contain errors
In pulmonary artery banded pigs, worsening right ventricular dysfunction from RV ejection fraction 38±4% to 20±8% is linked to distinct cellular programs and targetable stress pathways.
- Open access
- 2 cites
AI summary · may contain errors
Vascular smooth muscle cell–derived osteoprotegerin drives pulmonary arterial hypertension in the SuHx mouse model, and VSMC-specific OPG deletion improves haemodynamics.
- Open access
AI summary · may contain errors
Recombinant BMP3 prevents and reverses pulmonary arterial hypertension in mice, and lung-targeted AAV1-BMP3 overexpression reverses remodeling and improves cardiac function in mice and rats.
- Open access
- 2 cites
AI summary · may contain errors
Hepatopulmonary syndrome and portopulmonary hypertension are distinct pulmonary vascular complications in liver transplantation candidates, and both substantially increase morbidity and mortality.
- Open access
AI summary · may contain errors
Daily tadalafil treatment in bleomycin- or paraquat-induced rat pulmonary fibrosis attenuates fibrotic progression and lung injury, including when given at advanced disease stages.
AI summary · may contain errors
Impaired lysosomal lipid handling in endothelial cells and microglia is linked to a neurological disorder associated with pulmonary arterial hypertension (PAH), extending cardiometabolic–neurodegenerative evidence.
- Open access
AI summary · may contain errors
In UK Biobank patients with pulmonary hypertension (N = 248), reduced cerebellar white matter volume, thinner frontal gyri, and weaker cerebellar–frontal connectivity are linked to worse executive function and processing speed.
- Open access
- 1 cites
AI summary · may contain errors
A consensus expert framework proposes how to define disease modification in systemic sclerosis by integrating vascular, inflammatory, and fibrotic domains across heterogeneous patients.
- Open access
AI summary · may contain errors
[ 18 F]FDG PET shows a shift in right ventricular substrate use from fatty acid oxidation to glycolysis in pulmonary arterial hypertension, indicating metabolic stress and maladaptation.
- Open access
AI summary · may contain errors
Surfactant protein D (SP-D) is elevated in systemic sclerosis-related interstitial lung disease (SSc-ILD), with 17.36 ± 11.99 ng/mL versus 9.49 ± 7.92 ng/mL in SSc-NoILD.
- Open access
- 1 cites
AI summary · may contain errors
ERα loss-of-function in rat right ventricular endothelial cells reduces angiogenic behaviors and worsens RV capillary density, with stronger effects in females (e.g., 10 and 28 days).
- Open access
- 1 cites
AI summary · may contain errors
A severe systemic sclerosis (SSc) skin transcriptomic signature is linked to multiorgan involvement, showing increased skin fibrosis and decreased lung function (P < 0.05).
- Open access
- 2 cites
AI summary · may contain errors
Multi-modal human and mouse right ventricular pressure loading to failure atlas resolves a two-phase trajectory across 34 cell subtypes, with Phase 2 linked to spatially detected multi-lineage fibrotic and activation programs.
- Open access
- 1 cites
AI summary · may contain errors
EBF1+ endothelial cells in the adult Aplnr+ gCap compartment reconstitute an embryonic artery-forming niche in pulmonary arterial hypertension, and gCap-specific Ebf1 overexpression drives severe disease.
- Open access
- 3 cites
AI summary · may contain errors
About 20% to 30% of patients with systemic sclerosis-associated interstitial lung disease develop rapidly progressive pulmonary fibrosis, but dependable predictors remain elusive.
- Open access
- 2 cites
Browse JClub
Journals this month
- bioRxiv6412
- medRxiv1763
- PNAS556
- JAMA353
- Sci Adv330
- Cell Rep315
- Environ Res225
- BMJ217
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- Curr Biol148
- NEJM148
- New Phytol147
- Nature128
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
